Cargando…
Osteoclast-derived apoptotic bodies inhibit naive CD8(+) T cell activation via Siglec15, promoting breast cancer secondary metastasis
The bone microenvironment promotes cancer cell proliferation and dissemination. During periodic bone remodeling, osteoclasts undergo apoptosis, producing large numbers of apoptotic bodies (ABs). However, the biological role of osteoclast-derived ABs, which are residents of the bone-tumor niche, rema...
Autores principales: | Wu, Yutong, Ai, Hongbo, Xi, Yuhang, Tan, Jiulin, Qu, Ying, Xu, Jianzhong, Luo, Fei, Dou, Ce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518580/ https://www.ncbi.nlm.nih.gov/pubmed/37607544 http://dx.doi.org/10.1016/j.xcrm.2023.101165 |
Ejemplares similares
-
Reduced osteoclast-derived apoptotic bodies in bone marrow characterizes the pathological progression of osteoporosis
por: Wu, Yutong, et al.
Publicado: (2023) -
Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling
por: Ma, Qinyu, et al.
Publicado: (2021) -
Osteoclast-derived apoptotic bodies show extended biological effects of parental cell in promoting bone defect healing
por: Ma, Qinyu, et al.
Publicado: (2020) -
Osteoclast-derived small extracellular vesicles induce osteogenic differentiation via inhibiting ARHGAP1
por: Liang, Mengmeng, et al.
Publicado: (2021) -
Development of an Immunohistochemical Assay for Siglec-15
por: Shafi, Saba, et al.
Publicado: (2022)